FDA
approval
· 2024-03-21
FDA Approved: DICLOFENAC SODIUM MISOPROSTOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Diclofenac Sodium with Misoprostol (Nivagen Pharmaceuticals, Inc.). The labeling supports use for relief of signs an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DICLOFENAC SODIUM MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)